VPS Healthcare

vpshealth.com

VPS Healthcare is an integrated healthcare service provider with 22 operational hospitals, over 125 healthcare centres, 13000 employees, one of the largest pharmaceutical manufacturing plants in Dubai and medical support services spread across the Middle East, Europe and India. By providing comprehensive patient management at international quality standards across the MENA Region and beyond and to the entire strata of community, VPS Healthcare reflects a brand image of excellence in healthcare delivery system. VPS Healthcare is recognized as an Industry Partner by the World Economic Forum (WEF) and is also a member of the MENA Regional Partnership Community of the WEF. In addition to this, VPS Healthcare is also the proud holder of the Guinness World Record for Largest Simultaneous Self-Examination for Breast Cancer 2014.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Digital Healthcare

REDOX AND VOLUNTIS PARTNER TO IMPROVE THE INTEGRATION OF DIGITAL THERAPEUTICS WITH EHR

Voluntis | October 29, 2020

news image

Voluntis, an innovator in advanced therapeutics, declared today its vital organization with Redox, the main interoperability stage for medical services information trade. The association will permit suppliers to computerize and adjust experiences on their patients' treatment venture inside their Electronic Health Records (EHR) to improve care and cooperation. Redox and Voluntis will cooperate with an end goal to imp...

Read More

Future of Healthcare

SKYLIGHT HEALTH ANNOUNCES SERIES A PREFERRED STOCK CASH DIVIDEND

Skylight Health Group | December 14, 2022

news image

Skylight Health Group Inc. a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares for the month of January 2023. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol....

Read More

Health Technology

OVATION HEALTHCARE EXPANDS PORTFOLIO WITH LAUNCH OF TEMPO TECHNOLOGY SERVICES

PR Newswire | October 25, 2023

news image

Ovation Healthcare, a premier provider of shared services to independent hospitals and health systems nationwide, today announced the launch of Tempo Technology Services (Tempo). Tempo will complement the Ovation Healthcare portfolio with managed and professional IT services in addition to procurement of hardware, logistics services, and other devices to simplify decision making...

Read More

Future of Healthcare

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

news image

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More
news image

Digital Healthcare

REDOX AND VOLUNTIS PARTNER TO IMPROVE THE INTEGRATION OF DIGITAL THERAPEUTICS WITH EHR

Voluntis | October 29, 2020

Voluntis, an innovator in advanced therapeutics, declared today its vital organization with Redox, the main interoperability stage for medical services information trade. The association will permit suppliers to computerize and adjust experiences on their patients' treatment venture inside their Electronic Health Records (EHR) to improve care and cooperation. Redox and Voluntis will cooperate with an end goal to imp...

Read More
news image

Future of Healthcare

SKYLIGHT HEALTH ANNOUNCES SERIES A PREFERRED STOCK CASH DIVIDEND

Skylight Health Group | December 14, 2022

Skylight Health Group Inc. a healthcare platform combining technology and analytics focused on transitioning patients into value based care to drive better health outcomes and experiences in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares for the month of January 2023. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol....

Read More
news image

Health Technology

OVATION HEALTHCARE EXPANDS PORTFOLIO WITH LAUNCH OF TEMPO TECHNOLOGY SERVICES

PR Newswire | October 25, 2023

Ovation Healthcare, a premier provider of shared services to independent hospitals and health systems nationwide, today announced the launch of Tempo Technology Services (Tempo). Tempo will complement the Ovation Healthcare portfolio with managed and professional IT services in addition to procurement of hardware, logistics services, and other devices to simplify decision making...

Read More
news image

Future of Healthcare

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us